CTI BioPharma Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Millions NGN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	2011 - 2015
Period Ending	Jul '25 Jul 31, 2025	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	2011 - 2015
Market Capitalization	2,582	2,582	2,582	2,582	6,456	5,997	Upgrade
Market Cap Growth	-	-	-	-60.00%	7.65%	0%	Upgrade
Enterprise Value	3,200	2,619	2,756	2,756	7,044	6,733	Upgrade
PE Ratio	-	-	-	104.12	23.84	-	Upgrade
PS Ratio	3.17	3.17	1.04	0.71	1.39	1.62	Upgrade
PB Ratio	-1.83	-1.83	0.66	0.48	1.24	1.29	Upgrade
P/FCF Ratio	-	-	-	7.67	16.07	-	Upgrade
P/OCF Ratio	-	-	-	7.62	16.01	-	Upgrade
EV/Sales Ratio	3.93	3.22	1.11	0.76	1.52	1.81	Upgrade
EV/EBITDA Ratio	-	-	13.19	66.47	19.01	-	Upgrade
EV/EBIT Ratio	-	-	39.84	-	35.95	-	Upgrade
EV/FCF Ratio	-4.70	-	-	8.18	17.53	-	Upgrade
Debt / Equity Ratio	-1.26	-1.26	0.43	0.26	0.26	0.29	Upgrade
Debt / EBITDA Ratio	-	-	8.12	33.37	3.62	-	Upgrade
Debt / FCF Ratio	-	-	-	4.11	3.34	-	Upgrade
Quick Ratio	0.47	0.47	0.36	0.30	0.21	0.09	Upgrade
Current Ratio	0.69	0.69	0.63	0.52	0.44	0.34	Upgrade
Asset Turnover	0.09	0.09	0.20	0.27	0.36	0.30	Upgrade
Return on Equity (ROE)	-171.93%	-171.93%	-26.22%	0.47%	5.49%	-29.02%	Upgrade
Return on Assets (ROA)	-14.79%	-14.79%	0.35%	-0.48%	0.94%	-6.42%	Upgrade
Return on Capital (ROIC)	-46.71%	-46.71%	0.70%	-0.97%	1.95%	-13.81%	Upgrade
Earnings Yield	-84.16%	-84.16%	-47.08%	0.96%	4.19%	-20.42%	Upgrade
Earnings Yield	-84.16%	-84.16%	-47.08%	0.96%	4.19%	-20.42%	Upgrade
FCF Yield	-26.36%	-26.36%	-13.44%	13.05%	6.22%	-6.23%	Upgrade
Buyback Yield / Dilution	1.48%	-	-	-	-5.44%	0.08%	Upgrade

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.